Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 8861–8880 of 17,529 recalls

July 20, 2018· King Bio Inc.

Recalled Item: Dr. King's SafeCare Rx CS-Lymph Hodgkins

The Issue: Microbial contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 20, 2018· King Bio Inc.

Recalled Item: Dr. King's SafeCare Rx LymePlex

The Issue: Microbial contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
July 18, 2018· Avkare Incorporated

Recalled Item: AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Avkare Incorporated

Recalled Item: AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Avkare Incorporated

Recalled Item: AvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Avkare Incorporated

Recalled Item: AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Avkare Incorporated

Recalled Item: AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tablets 90-count bottle

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Northwind Pharmaceuticals LLC

Recalled Item: Valsartan HCTZ

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Northwind Pharmaceuticals LLC

Recalled Item: Valsartan

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Northwind Pharmaceuticals LLC

Recalled Item: Valsartan

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Northwind Pharmaceuticals LLC

Recalled Item: Valsartan

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· Hetero Labs, Ltd. - Unit III

Recalled Item: Indomethacin Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· VENSUN PHARMACEUTICALS INC

Recalled Item: Potassium Citrate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· VENSUN PHARMACEUTICALS INC

Recalled Item: Potassium Citrate Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· MAJOR PHARMACEUTICALS

Recalled Item: Unit Dose Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 18, 2018· MAJOR PHARMACEUTICALS

Recalled Item: Unit Dose Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
July 17, 2018· A-S Medication Solutions LLC.

Recalled Item: Valsartan and Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 17, 2018· A-S Medication Solutions LLC.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 17, 2018· A-S Medication Solutions LLC.

Recalled Item: Valsartan and Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
July 17, 2018· A-S Medication Solutions LLC.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund